You are here

Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2002 R43 CA096053 PAR-01-105 BECKER, CHRISTOPHER SURROMED, INC. AFFINITY MASS TAGS FOR DIFFERENTIAL PHENOTYPING Complete
2006 R21 CA118631 RFA-CA-06-003 CREWS, CRAIG M YALE UNIVERSITY ANALYSIS OF TUMORIGENIC SIGNALING PATHWAYS WITH PROTACS Complete
2009 R21 CA138365 RFA-CA-08-006 KRON, STEPHEN J. UNIVERSITY OF CHICAGO IMAGING DNA DAMAGE DYNAMICS FOR DIAGNOSTICS, SCREENING AND TARGET DISCOVERY Complete
2012 R21 CA157298 RFA-CA-12-004 AKSAN, ALPTEKIN UNIVERSITY OF MINNESOTA DEVELOPMENT OF ROOM-TEMPERATURE STORAGE TECHNIQUE FOR PLASMA/SERUM BIOSPECIMENS Complete
2016 R21 CA206953 RFA-CA-15-002 HAUN, JERED BRACKSTON UNIVERSITY OF CALIFORNIA-IRVINE TRANSFORMING FLUORESCENCE LIFETIME IMAGING MICROSCOPY INTO A FAST AND SIMPLE PLATFORM FOR HIGH-CONTENT MOLECULAR ANALYSIS Complete
2019 R33 CA225549 RFA-CA-18-003 TAVANA, HOSSEIN UNIVERSITY OF AKRON A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery Complete
2016 R21 CA202852 RFA-CA-15-002 HELD, JASON M. WASHINGTON UNIVERSITY DEVELOPMENT OF NOVEL CHEMICAL PROBES TO MAP S-NITROSYLATION IN CANCER Complete
2019 R33 CA229042 RFA-CA-18-003 SCHNECK, JONATHAN P JOHNS HOPKINS UNIVERSITY A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells Complete
2000 R21 CA088326 PAR-99-100 WEISSMAN, SHERMAN MORTON YALE UNIVERSITY DISPLAY METHODS FOR SURVEYING MUTATIONS Complete
2002 R21 CA094340 PAR-99-102 MEHTA, ANAND S THOMAS JEFFERSON UNIVERSITY IDENTIFICATION OF SERUM GLYCOSYLATION MARKERS OF HCC Complete
2005 R21 CA112149 RFA-CA-05-004 MELDRUM, DEIRDRE R. UNIVERSITY OF WASHINGTON AUTOMATED CELL PREPARATION IN TUBES FOR 3D MICROSCOPY Complete
2008 R21 CA125397 RFA-CA-07-035 EDWARDS, JEREMY S. UNIVERSITY OF NEW MEXICO SEQUENCING CHR. 6 IN MELANOMA PATIENTS Complete
2011 R21 CA155424 RFA-CA-10-005 LAVIE, ARNON UNIVERSITY OF ILLINOIS AT CHICAGO ENZYME-DELIVERY SCAFFOLD TECHNOLOGY FOR TARGETED CANCER KILLING. Complete
2015 R21 CA196455 RFA-CA-14-005 GERTZ, JASON UNIVERSITY OF UTAH DEVELOPMENT OF ENHANCER RNA-BASED BIOMARKERS IN FFPE TISSUE Complete
2018 R33 CA229023 RFA-CA-17-011 TEWARI, MUNEESH (contact); WALTER, NILS G UNIVERSITY OF MICHIGAN AT ANN ARBOR Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations Complete
1999 R43 CA081903 PAR-98-066 TS'O, PAUL O. P. CCC DIAGNOSTICS, LLC ISOLATION AND PROFILING OF CIRCULATING PC CELLS IN BLOOD Complete
2001 R43 CA093155 PAR-99-101 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS WHOLE GENOME METHYLATION ASSAY Complete
2004 R43 CA107764 PAR-01-105 VYKOUKAL, JODY V ADEPTAS, INC. RARE CELL ISOLATION FOR MORPHOLOGICAL & MOLECULAR STUDY Complete
2007 R41 CA128782 RFA-CA-07-011 CAO, HAN BIONANOMATRIX, INC. CONTINUOUS CHROMOSOME SORTING WITH MICRO/NANOFLUIDICS Complete
2010 R21 CA143177 RFA-CA-09-008 LEE, CHENG S UNIV OF MARYLAND, COLLEGE PARK CITP-BASED SELECTIVE TISSUE PROTEOME ENRICHMENT Complete
2014 R33 CA183671 RFA-CA-13-002 PARKER, LAURIE L. UNIVERSITY OF MINNESOTA MULTIPLEXED KINASE BIOSENSOR TECHNOLOGY TO DETECT LEUKEMIA SIGNALING WITH MASS SP Complete
2017 R33 CA212973 RFA-CA-16-002 YATES, JOHN R SCRIPPS RESEARCH INSTITUTE Measurement of Aberrant Protein Folds in Malignant Cells with Proteomics and Mass Spectrometry Complete
2001 R33 CA084691 PAR-98-067 MELDRUM, DEIRDRE R. UNIVERSITY OF WASHINGTON AUTOMATED MINIMAL RESIDUAL DISEASE QUANTIFICATION Complete
2003 R41 CA103103 PAR-01-105 SANTANGELO, PHILIP J VIVONETICS, INC. IN VIVO GENE EXPRESSION IMAGING FOR CANCER ANALYSIS Complete
2007 R21 CA116103 RFA-CA-07-002 XU, XIAOWEI UNIVERSITY OF PENNSYLVANIA ULTRASENSITIVE FACTT ASSAYS FOR SERUM BIOMARKERS Complete
2009 R43 CA137737 RFA-CA-08-011 ZWICK, MICHAEL G ANDROBIOSYS, INC. PRIMARY XENOGRAFTS OF HUMAN TISSUE AS SURROGATES OF CANCER IN SITU Complete
2013 R33 CA173264 RFA-CA-12-003 TACKETT, ALAN JACKSON UNIV OF ARKANSAS FOR MED SCIS DEVELOPMENT OF MASSSQUIRM TO QUANTITATIVELY MEASURE LYSINE METHYLATION Complete
2016 R33 CA196445 RFA-CA-15-003 LAM, KIT S UNIVERSITY OF CALIFORNIA AT DAVIS GESI: a novel technology for functional imaging in living cells Complete
2020 R33 CA236670 RFA-CA-19-020 HIGGINSON, DANIEL SLOAN-KETTERING INST CAN RESEARCH Comprehensive Breakpoint Analyses For Simultaneous Quantification Of All Dna Double Strand Break Repair Pathways Complete
2000 R43 CA081787 PAR-99-101 BUTT, TAUSEEF R. LIFESENSORS, INC. LIVESENSORS FOR MOLECULAR PROFILING IN PROSTATE CANCER Complete
2002 R43 CA096056 PAR-01-105 STRAUME, TORE GENMETRIX, LLC ASSAY FOR DETECTION OF CANCER CHROMOSOME ABNORMALITIES Complete
2006 R21 CA122890 RFA-CA-06-003 HAAB, BRIAN B. VAN ANDEL RESEARCH INSTITUTE DEFINING SECRETED GLYCAN ALTERATIONS IN PANCREATIC CANCER Complete
2009 R21 CA137695 RFA-CA-08-006 MANALIS, SCOTT R MASSACHUSETTS INSTITUTE OF TECHNOLOGY DEVELOPING A SINGLE CELL GROWTH MONITOR FOR CLASSIFYING THERAPEUTIC RESPONSE Complete
2012 R33 CA173382 RFA-CA-12-003 ZU, YOULI METHODIST HOSPITAL RESEARCH INSTITUTE ACTIVATABLE ONE-DROP AND ONE-STEP ASSAY FOR CIRCULATING TUMOR CE Complete
2012 R33 CA160132 RFA-CA-12-003 LAM, KIT S UNIVERSITY OF CALIFORNIA AT DAVIS DISCOVERY OF DEATH LIGANDS AGAINST CANCERS Complete
2016 R21 CA202875 RFA-CA-15-002 LARMAN, HARRY BENJAMIN JOHNS HOPKINS UNIVERSITY A HIGHLY MULTIPLEXED GENE EXPRESSION PLATFORM FOR FIXED TISSUE SPECIMENS Complete
2019 R33 CA229068 RFA-CA-18-003 SCHIAVINATO EBERLIN, LIVIA UNIVERSITY OF TEXAS, AUSTIN Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation Complete
2000 R21 CA088351 PAR-99-100 FU, XIANG-DONG UNIVERSITY OF CALIFORNIA SAN DIEGO CANCER CLASSIFICATION BASED ON MRNA ISOFORMS Complete
2002 R33 CA096309 PAR-01-104 LI, HONGHUA UNIV OF MED/DENT NJ-R W JOHNSON MED SCH A GENETIC APPROACH TO GENOME-SCALE ANALYSIS OF CANCERS Complete
2005 R21 CA111994 RFA-CA-05-004 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INSTITUTE GENOME AMPLIFICATION TOLERANT TO SAMPLE DEGRADATION Complete
2008 R21 CA125336 RFA-CA-07-035 NOLTE, DAVID D PURDUE UNIVERSITY WEST LAFAYETTE MULTIPLEXED ASSAYS ON THE BIOCD FOR ACUTE LYMPHOCYTIC LEUKEMIA Complete
2011 R21 CA157366 RFA-CA-10-005 LEVY, MATTHEW ALBERT EINSTEIN COLLEGE OF MEDICINE TARGETING CANCER CELLS WITH FUNCTIONALIZED NANOPARTICLE LIBRARIES Complete
2015 R21 CA196468 RFA-CA-14-005 KRUMMEL, MATTHEW F UNIVERSITY OF CALIFORNIA, SAN FRANCISCO LIVING TUMOR BIOPSIES TO INTERROGATE IMMUNE FUNCTION AND RESPONSE TO THERAPY Complete
2018 R21 CA229037 RFA-CA-17-012 GULLEY, MARGARET L UNIV OF NORTH CAROLINA CHAPEL HILL EndoGenus Toolkit: A Biometric Method for Absolute Quantification of Tumor Markers by Massive Parallel Sequencing Complete
1999 R43 CA081949 PAR-98-066 OLINER, JONATHAN D AFFYMETRIX, INC. REVERSE-ENGINEERING SIGNAL TRANSDUCTION NETWORKS Complete
2001 R43 HL069675 PAR-99-101 WILLETT, CATHERINE E PHYLONIX PHARMACEUTICALS, INC. ASSAY FOR IDENTIFYING ANGIOGENIC DRUG TARGETS Complete
2004 R43 CA108005 PAR-01-105 HEILIG, JOSEPH S SOMALOGIC, INC. APTAMER DEVELOPMENT FOR CANCER DIAGNOSIS AND MANAGEMENT Complete
2007 R42 CA116048 RFA-CA-07-011 RAMPERSAUD, ARFAAN COLUMBUS NANOWORKS, INC. COMMERCIALIZATION OF MAGNETIC NANOBEADS FOR CANCER CELL ENRICHMENT Complete
2010 R33 CA138330 RFA-CA-09-005 WANG, SHAN X. STANFORD UNIVERSITY CANCER SAMPLE PREPARATION WITH MICROMACHINED MAGNETIC SIFTER AND NANOPARTICLES Complete
2014 R33 CA183685 RFA-CA-13-004 HANSEN, KIRK C UNIVERSITY OF COLORADO DENVER ADVANCED METHODS TO EVALUATE EXTRACELLULAR MATRIX AND CROSSLINKING IN THE TUMOR M Complete

Pages